Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Inhaled Nitric Oxide and Prostacyclin After Cardiac Surgery
NCT01717209Phase 4Completed
- Sponsor
- Stanford University
- Start
- Oct 2012
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of epoprostenol in pulmonary hypertension (PH), right ventricular failure (RVF), sponsored by Stanford University. Started Oct 2012; status: completed.
02
Drugs
epoprostenol
03
Conditions
pulmonary hypertension (PH)right ventricular failure (RVF)
Beyond the preview
Go deeper on NCT01717209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717209.